These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 33874899

  • 21. Unexpectedly high incidence of Kawasaki Disease in a Canadian Atlantic Province- an 11-year retrospective descriptive study.
    Alkanhal A, Saunders J, Altammar F, Huber AM, Lynk A, MacLeod A, Ortiz-Alvarez O, Adams M, Ramsey S, Stringer E, Warren A, Lang B.
    Pediatr Rheumatol Online J; 2023 Apr 03; 21(1):30. PubMed ID: 37013572
    [Abstract] [Full Text] [Related]

  • 22. Blood routine risk factors for coronary artery aneurysm in infants younger than 8 months with Kawasaki disease.
    Haiyan G, Jianming L, Suqian T, Dong Q, Shuang L, Jin Z.
    BMC Pediatr; 2022 Jan 07; 22(1):29. PubMed ID: 34996405
    [Abstract] [Full Text] [Related]

  • 23. Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD CAA prevention (KD-CAAP) trial protocol.
    Eleftheriou D, Moraes YC, Purvis C, Pursell M, Morillas MM, Kahn R, Mossberg M, Kucera F, Tulloh R, Standing JF, Swallow V, McCormack R, Herberg J, Levin M, Wan M, Klein N, Connon R, Walker AS, Brogan P.
    Trials; 2023 Jan 26; 24(1):60. PubMed ID: 36703139
    [Abstract] [Full Text] [Related]

  • 24. Reevaluation of the efficacy of intravenous gammaglobulin in the prevention and treatment of coronary artery lesion in Kawasaki disease.
    Qin L, Saumu MT, Wang H, Shi H, Hu X, Cheng P.
    J Huazhong Univ Sci Technolog Med Sci; 2005 Jan 26; 25(3):348-50, 370. PubMed ID: 16201293
    [Abstract] [Full Text] [Related]

  • 25. An evaluation of children with Kawasaki disease in Istanbul: a retrospective follow-up study.
    Kayiran SM, Dindar A, Gurakan B.
    Clinics (Sao Paulo); 2010 Jan 26; 65(12):1261-5. PubMed ID: 21340213
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Relationship between ocular manifestations, laboratory findings, echocardiographic findings, and intravenous immunoglobulin resistance in Kawasaki disease.
    Jari M, Esmaeili H.
    Pediatr Rheumatol Online J; 2024 May 01; 22(1):50. PubMed ID: 38693550
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Importance of C-reactive protein level in predicting non-response to additional intravenous immunoglobulin treatment in children with Kawasaki disease: a retrospective study.
    Iwashima S, Kimura M, Ishikawa T, Ohzeki T.
    Clin Drug Investig; 2011 May 01; 31(3):191-9. PubMed ID: 21456105
    [Abstract] [Full Text] [Related]

  • 32. Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during SARS-CoV-2 epidemic in Italy: results from a national, multicenter survey.
    Cattalini M, Della Paolera S, Zunica F, Bracaglia C, Giangreco M, Verdoni L, Meini A, Sottile R, Caorsi R, Zuccotti G, Fabi M, Montin D, Meneghel A, Consolaro A, Dellepiane RM, Maggio MC, La Torre F, Marchesi A, Simonini G, Villani A, Cimaz R, Ravelli A, Taddio A, Rheumatology Study Group of the Italian Pediatric Society.
    Pediatr Rheumatol Online J; 2021 Mar 16; 19(1):29. PubMed ID: 33726806
    [Abstract] [Full Text] [Related]

  • 33. Evaluation of laboratory predictors for intravenous immunoglobulin resistance and coronary artery aneurysm in Kawasaki Disease before and after therapy.
    Liu J, Ye B, Su D, Qin S, Zhao W, Pang Y.
    Clin Rheumatol; 2023 Jan 16; 42(1):167-177. PubMed ID: 36129563
    [Abstract] [Full Text] [Related]

  • 34. Comparison of Risk of Recrudescent Fever in Children With Kawasaki Disease Treated With Intravenous Immunoglobulin and Low-Dose vs High-Dose Aspirin.
    Platt B, Belarski E, Manaloor J, Ofner S, Carroll AE, John CC, Wood JB.
    JAMA Netw Open; 2020 Jan 03; 3(1):e1918565. PubMed ID: 31899532
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Has joint involvement lessened in Kawasaki disease?
    Álvarez EP, Rey F, Peña SC, Rubio A, Calvo C, Collado P.
    Reumatol Clin; 2017 Jan 03; 13(3):145-149. PubMed ID: 27263965
    [Abstract] [Full Text] [Related]

  • 37. Clinical relevance of the risk factors for coronary artery inflammation in Kawasaki disease.
    Honkanen VE, McCrindle BW, Laxer RM, Feldman BM, Schneider R, Silverman ED.
    Pediatr Cardiol; 2003 Jan 03; 24(2):122-6. PubMed ID: 12457252
    [Abstract] [Full Text] [Related]

  • 38. The clinical profile of Kawasaki disease of children from three Polish centers: a retrospective study.
    Gorczyca D, Postępski J, Olesińska E, Lubieniecka M, Lachór-Motyka I, Opoka-Winiarska V, Gruenpeter A.
    Rheumatol Int; 2014 Jun 03; 34(6):875-80. PubMed ID: 23893035
    [Abstract] [Full Text] [Related]

  • 39. A 5-year-old boy with only fever and giant coronary aneurysms: the enigma of Kawasaki disease?
    Vignesh P, Bhattad S, Singhal M, Singh S.
    Rheumatol Int; 2016 Aug 03; 36(8):1191-3. PubMed ID: 27154559
    [Abstract] [Full Text] [Related]

  • 40. [Association between duration of fever before treatment and intravenous immunoglobulin resistance in Kawasaki disease].
    Wang X, Pan SL, DU ZH, Ji ZX, Luo G, Sun HX, Ma SJ.
    Zhongguo Dang Dai Er Ke Za Zhi; 2022 Apr 15; 24(4):399-404. PubMed ID: 35527415
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.